Results 161 to 164 of about 7,433 (164)

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation. [PDF]

Drug Des Devel Ther
Lu W, Yang Z, Wang M, Zhang Y, Qi Z, Yang X.   +5 more
europepmc   +1 more source

Efficacy of 0.5% Timolol Maleate versus 0.05% Clobetasol Propionate in Treating Superficial Infantile Hemangioma: A Pilot Randomized Controlled Trial.

J Indian Assoc Pediatr Surg
Singh S, Srivastava NK, Upadhyaya A, Kumar M, Pawar N, Kapoor R.   +5 more
europepmc   +1 more source

Once a day administration of R(+) propranolol is sufficient to block vasculogenesis in a xenograft model of infantile hemangioma. [PDF]

J Vasc Anom (Phila)
Holm A, Tan JWH, Borgelt L, Mulliken JB, Bischoff J.   +4 more
europepmc   +1 more source

Characteristics and Outcomes of Infantile Hemangioma With Non, Poor, and Partial Response to Standard-Dose Systemic Beta-Blocker Therapy

Mohsen Afarideh, Katinna E. Rodriguez Baisi, Nessa Aghazadeh, Kimberly D. Morel, Gerilyn M. Olsen, Denise M. Adams, Amy J. Nopper, Eulàlia Baselga, Ilona J. Frieden, Maria C. Garzón, Kimberly A. Horii, Christine T. Lauren, Erin F. Mathes, Catherine McCuaïg, Brandon Newell, Julie Powell, Sonal D. Shah, Megha M. Tollefson   +17 more
openalex   +1 more source